A Phase IIA Trial of Two Schedules of Perifosine.

Trial Profile

A Phase IIA Trial of Two Schedules of Perifosine.

Phase of Trial: Phase II

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Perifosine (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AEterna Zentaris Inc
  • Most Recent Events

    • 04 Mar 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
    • 16 Oct 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 16 Oct 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top